← Back to Search

Peer Comparison Feedback for High Blood Pressure

N/A
Waitlist Available
Led By Shivan Mehta, MD,MBA,MSHP
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
It also excludes patients with an end of life indicator (comfort care encounter in the last year, comfort care noted in problem list in the last year, and comfort care/palliative care procedures in the last year)
Patients will be excluded if they are 66 and older with a frailty diagnosis and those with an advanced illness diagnosis within the past year; 81 and older with frailty diagnosis within the past year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare whether monthly peer comparison messages to primary care providers will increase provider engagement with patients' overall hypertension management.

Who is the study for?
This trial is for Primary Care Providers at Penn Medicine Lancaster with at least 30 patients who have high blood pressure. These patients must be aged 18-85 and have had a diagnosis of hypertension in the last two years. Excluded are providers with fewer than 30 such patients, those caring for patients with end stage renal disease, recent pregnancy, or indicators of end-of-life care.
What is being tested?
The study tests if sending monthly peer comparison messages to doctors can improve how they manage high blood pressure. It looks at whether these messages encourage doctors to start or increase doses of blood pressure medications among their patients.
What are the potential side effects?
Since this trial involves communication strategies rather than medical treatments, there are no direct side effects related to drugs or interventions typically associated with clinical trials.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have not been in comfort or palliative care in the last year.
Select...
I am not over 65 with frailty or have had an advanced illness diagnosis in the past year.
Select...
I do not have end stage kidney disease or been pregnant in the last 9 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in new hypertensive medication prescriptions or an increased dose of hypertensive medication
Secondary study objectives
Change in hypertension control percentage

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
This group will receive peer comparison messages.
Group II: ControlActive Control1 Intervention
This group will not receive peer comparison messages and will continue with usual care.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,073 Previous Clinical Trials
42,714,163 Total Patients Enrolled
Shivan Mehta, MD,MBA,MSHPPrincipal InvestigatorUniversity of Pennsylvania
1 Previous Clinical Trials
80,063 Total Patients Enrolled

Media Library

Peer Comparison Message Clinical Trial Eligibility Overview. Trial Name: NCT05160012 — N/A
High Blood Pressure Research Study Groups: Control, Intervention
High Blood Pressure Clinical Trial 2023: Peer Comparison Message Highlights & Side Effects. Trial Name: NCT05160012 — N/A
Peer Comparison Message 2023 Treatment Timeline for Medical Study. Trial Name: NCT05160012 — N/A
~26 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top